SEC Form 4 · accession 0001752968-26-000010
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helmy Eltoukhy
Officer — Co-Chief Executive Officer · Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 6:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | S | 49,716 | $125.569 | D | 2,063,203 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
| Common StockF2 | Jun 5, 2026 | S | 33,843 | $126.3263 | D | 2,029,360 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
| Common StockF3 | Jun 5, 2026 | S | 1,100 | $127.0241 | D | 2,028,260 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
| Common StockF4 | Jun 5, 2026 | S | 13,787 | $128.2511 | D | 2,014,473 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
| Common StockF5 | Jun 5, 2026 | S | 554 | $130.2054 | D | 2,013,919 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
| Common StockF6 | Jun 5, 2026 | S | 900 | $131.7844 | D | 2,013,019 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
| Common Stock | Jun 5, 2026 | S | 100 | $132.55 | D | 2,012,919 | I | Shares held by Helmy A. Eltoukhy Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $124.95 to $125.94. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.95 to $126.93. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $126.965 to $127.030. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $128.250 to $128.335. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $130.02 to $131.00. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F6Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.36 to $132.18. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.